Diabetes mellitus and prostate cancer risk in Asian countries: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 4097-4100

  Long, Xiang Ju ^a   Lin, Shan ^a   Sun, Ya Nan ^a   Zheng, Zhen Feng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Asian populations; Diabetes mellitus; Meta analysis; Prostate cancer

Indexed keywords

EID: 84873658478     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.4097     Document Type: Article

References (28)

1. Barone BB, Yeh HC, Snyder CF, et al (2008). Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA, 300, 2754-64.
2. Bonovas S, Filioussi K, Tsantes A (2004). Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia, 47, 1071-8.
3. Chan JC, Malik V, Jia W, et al (2009). Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA, 301, 2129-40.
4. Chen CQ, Fang LK, Cai SR, et al (2010). Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J (Engl), 123, 3084-8.
5. Chiou WK, Hwang JS, Hsu KH, et al (2012). Diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients. Exp Diabetes Res, 2012, 701643.
6. Damber JE, Aus G (2008). Prostate cancer. Lancet, 371, 1710-21.
7. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
8. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
9. Foulkes WD (2008). Inherited susceptibility to common cancers. N Engl J Med, 359, 2143-53.
10. Fukushima H, Masuda H, Kawakami S, et al (2012). Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology, 79, 1329-34.
11. Ganesh B, Saoba SL, Sarade MN, et al (2011). Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India. Indian J Urol, 27, 345-50.
12. Gann PH, Hennekens CH, Ma J, et al (1996). Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst, 88, 1118-26.
13. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
14. Hoffman RM (2011). Clinical practice. Screening for prostate cancer. N Engl J Med, 365, 2013-9.
15. Hong SK, Oh JJ, Byun SS, et al (2012). Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (>/= 12)-core prostate biopsy. Prostate, 72, 51-7.
16. Hsieh MC, Lee TC, Cheng SM, et al (2012). The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the taiwanese. Exp Diabetes Res, 2012, 413782.
17. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
18. Kasper JS, Giovannucci E (2006). A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 15, 2056-62.
19. Lee MY, Lin KD, Hsiao PJ, et al (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9.
20. Li Q, Kuriyama S, Kakizaki M, et al (2010). History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study. Cancer Causes Control, 21, 1025-32.
21. McGrowder DA, Jackson LA, Crawford TV (2012). Prostate cancer and metabolic syndrome: is there a link? Asian Pac J Cancer Prev, 13, 1-13.
22. Mori M, Masumori N, Fukuta F, et al (2011). Weight gain and family history of prostate or breast cancers as risk factors for prostate cancer: results of a case-control study in Japan. Asian Pac J Cancer Prev, 12, 743-7.
23. Nolan CJ, Damm P, Prentki M (2011). Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet, 378, 169-81.
24. Onitilo AA, Engel JM, Glurich I, et al (2012). Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control, 23, 967-81.
25. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, et al (2000). Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control, 11, 707-11.
26. Snyder CF, Stein KB, Barone BB, et al (2010). Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. Prostate Cancer Prostatic Dis, 13, 58-64.
27. Tseng CH (2011). Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care, 34, 616-21.
28. Tsugane S, Inoue M (2010). Insulin resistance and cancer: epidemiological evidence. Cancer Sci, 101, 1073-9.